The Placenta in Toxicology. Part IV:Battery of Toxicological Test Systems Based on Human Placenta

Toxicologic Pathology

Volumn 42, Issue 2, 2014, Pages 345-351

  Göhner, Claudia ^a   Svensson Arvelund, Judit ^b   Pfarrer, Christiane ^c   Häger, Jan Dirk ^c   Faas, Marijke ^d   Ernerudh, Jan ^b   Cline, J Mark ^e   Dixon, Darlene ^f   Buse, Eberhard ^g   Markert, Udo R ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^g Covance Laboratories ^*  (Germany)

Author keywords

choriocarcinoma; human toxicology; placenta; placenta explant; placenta perfusion; trophoblast

Indexed keywords

CHORIOCARCINOMA; HUMAN TOXICOLOGY.; PLACENTA; PLACENTA EXPLANT; PLACENTA PERFUSION; TROPHOBLAST;

FEMALE; HUMANS; PLACENTA; PREGNANCY; TOXICITY TESTS;

BIOLOGICAL MARKER;

CELL DEATH; CELL ISOLATION; CELL PROLIFERATION; CELL TYPE; ENDOTHELIUM CELL; EX VIVO STUDY; EXPLANT; FIBROBLAST; GENE EXPRESSION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MEMBRANE; METABOLISM; NONHUMAN; PLACENTA; PLACENTA PERFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SPECIES DIFFERENCE; STEM CELL; TOXICITY; TOXICOLOGY; TRANSPORT KINETICS; TROPHOBLAST; WORKLOAD;

EID: 84893551330     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623313482206     Document Type: Article

References (59)

1. Akhter A. Das V. Naik S. Faridi R. M. Pandey A. Agrawal S. (2012). Upregulation of HLA-G in JEG-3 cells by dexamethasone and hydrocortisone. Arch Gynecol Obstet 285, 7–14.
2. Bahn R. S. Worsham A. Speeg K. V. Jr Ascoli M. Rabin D. (1981). Characterization of steroid production in cultured human choriocarcinoma cells. J Clin Endocrinol Metab 52, 447–50.
3. Balakrishnan B. Thorstensen E. Ponnampalam A. Mitchell M. D. (2011). Passage of 4-nonylphenol across the human placenta. Placenta 32, 788–92.
4. Bechi N. Ietta F. Romagnoli R. Focardi S. Corsi I. Buffi C. Paulesu L. (2006). Estrogen-like response to p-nonylphenol in human first trimester placenta and BeWo choriocarcinoma cells. Toxicol Sci 93, 75–81.
5. Benirschke K. (2007). Comparative placentation. http://placentation.ucsd.edu/. Accessed March 9, 2013.
6. Bilban M. Tauber S. Haslinger P. Pollheimer J. Saleh L. Pehamberger H. Wagner O. Knofler M. (2010). Trophoblast invasion: Assessment of cellular models using gene expression signatures. Placenta 31, 989–96.
7. Cannell G. R. Kluck R. M. Hamilton S. E. Mortimer R. H. Hooper W. D. Dickinson R. G. (1988). Markers of physical integrity and metabolic viability of the perfused human placental lobule. Clin Exp Pharmacol Physiol 15, 837–44.
8. Carney E. W. Scialli A. R. Watson R. E. DeSesso J. M. (2004). Mechanisms regulating toxicant disposition to the embryo during early pregnancy: An interspecies comparison. Birth Defects Res Part C, Embryo Today 72, 345–60.
9. Carter A. M. Enders A. C. (2004). Comparative aspects of trophoblast development and placentation. Reprod Biol Endocrinol 2, 46.
10. Carter A. M. Mess A. (2010). Hans Strahl’s pioneering studies in comparative placentation. Placenta 31, 848–52.
11. Chen S. C. Liao T. L. Wei Y. H. Tzeng C. R. Kao S. H. (2010). Endocrine disruptor, dioxin (TCDD)-induced mitochondrial dysfunction and apoptosis in human trophoblast-like JAR cells. Mol Human Reprod 16, 361–72.
12. Cline J. M. Dixon D. Faas M. Göhner C. Häger J. D. Markert U. R. Pfarrer C. Ernerudh J. Svensson J. Buse E. (In Press). The placenta in toxicology. Part V. Pathologic assessment of the placenta. Toxicol Pathol.
13. de Oliveira Gomes A. de Oliveira Silva D. A. Silva N. M. de Freitas Barbosa B. Franco P. S. Angeloni M. B. Fermino M. L. Roque-Barreira M. C. Bechi N. Paulesu L. R. Dos Santos M. C. Mineo J. R. Ferro E. A. (2011). Effect of macrophage migration inhibitory factor (MIF) in human placental explants infected with Toxoplasma gondii depends on gestational age. Am J Pathol 178, 2792–801.
14. Fitzgerald J. S. Germeyer A. Huppertz B. Jeschke U. Knofler M. Moser G. Scholz C. Sonderegger S. Toth B. Markert U. R. (2010). Governing the invasive trophoblast: Current aspects on intra- and extracellular regulation. Am J Reprod Immunol 63, 492–505.
15. Giaginis C. Theocharis S. Tsantili-Kakoulidou A. (2012). Current toxicological aspects on drug and chemical transport and metabolism across the human placental barrier. Expert Opin Drug Metabol Toxicol 8, 1263–75.
16. Giaginis C. Tsantili-Kakoulidou A. Theocharis S. (2011). Assessing drug transport across the human placental barrier: From in vivo and in vitro measurements to the ex vivo perfusion method and in silico techniques. Curr Pharmaceut Biotechnol 12, 804–13.
17. Gong J. H. Maki G. Klingemann H. G. (1994). Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 8, 652–8.
18. Grabic R. Hansen L. G. Ptak A. Crhova S. Gregoraszczuk E. L. (2006). Differential accumulation of low-chlorinated (Delor 103) and high-chlorinated (Delor 106) biphenyls in human placental tissue and opposite effects on conversion of DHEA to E2. Chemosphere 62, 573–80.
19. Graham C. H. Hawley T. S. Hawley R. G. MacDougall J. R. Kerbel R. S. Khoo N. Lala P. K. (1993). Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 206, 204–11.
20. Guinazu N. Rena V. Genti-Raimondi S. Rivero V. Magnarelli G. (2012). Effects of the organophosphate insecticides phosmet and chlorpyrifos on trophoblast JEG-3 cell death, proliferation and inflammatory molecule production. Toxicol In Vitro 26, 406–13.
21. Halkoaho A. Pietila A. M. Dumez B. Van Damme K. Heinonen S. Vahakangas K. (2010). Ethical aspects of human placental perfusion: Interview of the mothers donating placenta. Placenta 31, 686–90.
22. Heinzelmann J. Enke U. Seyfarth L. Schleussner E. Malek A. Markert U. R. (2009). Development of a human model to study homing behavior of immune cells into decidua and placental villi under ex vivo conditions. Am J Reprod Immunol 61, 19–25.
23. Hiden U. Wadsack C. Prutsch N. Gauster M. Weiss U. Frank H. G. Schmitz U. Fast-Hirsch C. Hengstschlager M. Potgens A. Ruben A. Knofler M. Haslinger P. Huppertz B. Bilban M. Kaufmann P. Desoye G. (2007). The first trimester human trophoblast cell line ACH-3P: A novel tool to study autocrine/paracrine regulatory loops of human trophoblast subpopulations--TNF-alpha stimulates MMP15 expression. BMC Dev Biol 7, 137.
24. Huang H. Leung L. K. (2009). Bisphenol A downregulates CYP19 transcription in JEG-3 cells. Toxicol Lett 189, 248–52.
25. Hutson J. R. Garcia-Bournissen F. Davis A. Koren G. (2011). The human placental perfusion model: A systematic review and development of a model to predict in vivo transfer of therapeutic drugs. Clin Pharmacol Ther 90, 67–76.
26. Johnson G. E. (2012). Mammalian cell HPRT gene mutation assay: Test methods. Methods Mol Biol 817, 55–67.
27. Kammerer U. von Wolff M. Markert U. R. (2004). Immunology of human endometrium. Immunobiology 209, 569–74.
28. Kantola M. Purkunen R. Kroger P. Tooming A. Juravskaja J. Pasanen M. Saarikoski S. Vartiainen T. (2000). Accumulation of cadmium, zinc, and copper in maternal blood and developmental placental tissue: Differences between Finland, Estonia, and St. Petersburg. Environ Res 83, 54–66.
29. Kovo M. Haroutiunian S. Feldman N. Hoffman A. Glezerman M. (2008). Determination of metformin transfer across the human placenta using a dually perfused ex vivo placental cotyledon model. Eur J Obstet Gynecol Reprod Biol 136, 29–33.
30. Laville N. Balaguer P. Brion F. Hinfray N. Casellas C. Porcher J. M. Ait-Aissa S. (2006). Modulation of aromatase activity and mRNA by various selected pesticides in the human choriocarcinoma JEG-3 cell line. Toxicology 228, 98–108.
31. Lehman L. D. Poisner A. M. (1984). Induction of metallothionein synthesis in cultured human trophoblasts by cadmium and zinc. J Toxicol Environ Health 14, 419–32.
32. Male V. Gardner L. Moffett A. (2012). Isolation of cells from the feto-maternal interface. Current Protocols in Immunology (Coligan John E., eds.). Chapter 7, Unit 7 40 1–11. John Wiley and Sons, Hoboken, NJ.
33. Markert U. R. Morales-Prieto D. M. Fitzgerald J. S. (2011). Understanding the link between the IL-6 cytokine family and pregnancy: Implications for future therapeutics. Expet Rev Clin Immunol 7, 603–9.
34. Mattison D. R. (2010). Environmental exposures and development. Curr Opin Pediat 22, 208–18.
35. Miller R. K. Genbacev O. Turner M. A. Aplin J. D. Caniggia I. Huppertz B. (2005). Human placental explants in culture: Approaches and assessments. Placenta 26, 439–48.
36. Morales-Prieto D. M. Chaiwangyen W. Ospina-Prieto S. Schneider U. Herrmann J. Gruhn B. Markert U. R. (2012). MicroRNA expression profiles of trophoblastic cells. Placenta 33, 725–34.
37. Morck T. J. Sorda G. Bechi N. Rasmussen B. S. Nielsen J. B. Ietta F. Rytting E. Mathiesen L. Paulesu L. Knudsen L. E. (2010). Placental transport and in vitro effects of Bisphenol A. Reprod Toxicol 30, 131–7.
38. Mose T. Mathiesen L. Karttunen V. Nielsen J. K. Sieppi E. Kummu M. Morck T. A. Myohanen K. Partanen H. Vahakangas K. Knudsen L. E. Myllynen P. (2012). Meta-analysis of data from human ex vivo placental perfusion studies on genotoxic and immunotoxic agents within the integrated European project NewGeneris. Placenta 33, 433–9.
39. Noschel H. Reiber W. Schroder S. (1982). [Drug modification of contractions of fetoplacental vessels of bilaterally in vitro perfused human placentas]. Zentralblatt fur Gynakologie 104, 1149–54.
40. Partanen H. Vahakangas K. Woo C. S. Auriola S. Veid J. Chen Y. Myllynen P. El Nezami H. (2012). Transplacental transfer of melamine. Placenta 33, 60–66.
41. Pijnenborg R. Luyten C. Vercruysse L. Keith J. C. Jr Van Assche F. A. (2000). Cytotoxic effects of tumour necrosis factor (TNF)-alpha and interferon-gamma on cultured human trophoblast are modulated by fibronectin. Mol Human Reprod 6, 635–41.
42. Potgens A. J. Gaus G. Frank H. G. Kaufmann P. (2001). Characterization of trophoblast cell isolations by a modified flow cytometry assay. Placenta 22, 251–5.
43. Prouillac C. Koraichi F. Videmann B. Mazallon M. Rodriguez F. Baltas M. Lecoeur S. (2012). In vitro toxicological effects of estrogenic mycotoxins on human placental cells: Structure activity relationships. Toxicol Appl Pharmacol 259, 366–75.
44. Reiber W. Noschel H. Schroder S. Muller B. Gross W. Michels W. (1990). [Effects of various oxygen concentrations on metabolic performance of in vitro perfused human placentas]. Zentralblatt fur Gynakologie 112, 207–14.
45. Reichrtova E. Dorociak F. Palkovicova L. (1998). Sites of lead and nickel accumulation in the placental tissue. Hum Exp Toxicol 17, 176–81.
46. Ronco A. M. Llaguno E. Epunan M. J. Llanos M. N. (2010). Effect of cadmium on cortisol production and 11beta-hydroxysteroid dehydrogenase 2 expression by cultured human choriocarcinoma cells (JEG-3). Toxicol In Vitro 24, 1532–7.
47. Sanyal M. K. Li Y. L. Biggers W. J. Satish J. Barnea E. R. (1993). Augmentation of polynuclear aromatic hydrocarbon metabolism of human placental tissues of first-trimester pregnancy by cigarette smoke exposure. Am J Obstet Gynecol 168, 1587–97.
48. Schamberger S. Weber M. Sonnemann J. Markert U. R. (2013). Establishment of a one-sided ex vivo human placenta perfusion model to assess adhesion and invasion behavior of T cell leukemia cell lines. Leuk Lymphoma submitted [epub ahead of print].
49. Schneider H. Panigel M. Dancis J. (1972). Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am J Obstet Gynecol 114, 822–28.
50. Schniewind H. (1960). [An experimental apparatus for perfusion of the human placenta vessels]. Zeitschrift fur die gesamte experimentelle Medizin 132, 577–84.
51. Schropfer A. Kammerer U. Kapp M. Dietl J. Feix S. Anacker J. (2010). Expression pattern of matrix metalloproteinases in human gynecological cancer cell lines. BMC Cancer 10, 553.
52. Solder E. Bockle B. C. Nguyen V. A. Furhapter C. Obexer P. Erdel M. Stossel H. Romani N. Sepp N. T. (2012). Isolation and characterization of CD133+CD34+VEGFR-2+CD45- fetal endothelial cells from human term placenta. Microvasc Res 84, 65–73.
53. Troen P. Gordon E. E. (1958). Perfusion studies of the human placenta. I. Effect of estradiol and human chorionic gonadotropin on citric acid metabolism. J Clin Invest 37, 1516–23.
54. Trundley A. E. Hiby S. E. Chang C. Sharkey A. M. Santourlidis S. Uhrberg M. Trowsdale J. Moffett A. (2006). Molecular characterization of KIR3DL3. Immunogenetics 57, 904–16.
55. Urbach J. Boadi W. Brandes J. M. Kerner H. Yannai S. (1992). Effect of inorganic mercury on in vitro placental nutrient transfer and oxygen consumption. Reprod Toxicol 6, 69–75.
56. Vahakangas K. Myllynen P. (2009). Drug transporters in the human blood-placental barrier. Br J Pharmacol 158, 665–78.
57. Wimalasena J. Beams F. Caudle M. R. (1994). Ethanol modulates the hormone secretory responses induced by epidermal growth factor in choriocarcinoma cells. Alcohol Clin Exp Res 18, 1448–55.
58. Woo C. S. Partanen H. Myllynen P. Vahakangas K. El-Nezami H. (2012). Fate of the teratogenic and carcinogenic ochratoxin A in human perfused placenta. Toxicol Lett 208, 92–9.
59. Worley K. C. Roberts S. W. Bawdon R. E. (2008). The metabolism and transplacental transfer of oseltamivir in the ex vivo human model. Infect Dis Obstet Gynecol 2008, 927574.